Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
Cancer Immunology, Immunotherapy : CII
|
October 5, 2024
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era
Allison L Gradone, Vincent T Ma, Alexi Vasbinder, et al.
Journal of the American Academy of Dermatology
|
April 18, 2012
Effects of contiguous scars in dermatoscopic evaluation of clinically atypical melanocytic nevi
Hyuk C Cha, Mandy Harting, Kelly B Cha, et al.
Cancer
|
May 24, 2007
Merkel cell carcinoma: critical review with guidelines for multidisciplinary management
Christopher K Bichakjian, Lori Lowe, Christopher D Lao, et al.
Neuro-Oncology
|
January 16, 2016
Concurrent whole brain radiotherapy and RRx-001 for melanoma brain metastases
Michelle M Kim, Hemant Parmar, Yue Cao, et al.
American Journal of Clinical Pathology
|
October 23, 2012
Molecular diagnostics of melanoma fine-needle aspirates: a cytology-histology correlation study
Kurt D Bernacki, Bryan L Betz, Helmut C Weigelin, et al.
Advances in Radiation Oncology
|
December 22, 2021
Complete Response After Stereotactic Body Radiation Therapy With Concurrent Immunotherapy for Vaginal Melanoma
Caitlin A Schonewolf, Elizabeth M Jaworski, Steven G Allen, et al.
Cancer
|
April 10, 2004
Dysplasia in Barrett esophagus
Christopher D Lao, Melanie Simmons, Sapna Syngal, et al.
Journal of the American Academy of Dermatology
|
May 17, 2011
Feasibility of serial biopsies of large dysplastic nevi as a melanoma chemoprevention model
Christopher D Lao, Timothy Johnson, Vernon K Sondak, et al.
Plos One
|
December 11, 2012
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
Shailender Bhatia, James Moon, Kim A Margolin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2012
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438)
Kim A Margolin, James Moon, Lawrence E Flaherty, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
Cancer Immunology, Immunotherapy : CII
|
October 5, 2024
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era
Allison L Gradone, Vincent T Ma, Alexi Vasbinder, et al.
Journal of the American Academy of Dermatology
|
April 18, 2012
Effects of contiguous scars in dermatoscopic evaluation of clinically atypical melanocytic nevi
Hyuk C Cha, Mandy Harting, Kelly B Cha, et al.
Cancer
|
May 24, 2007
Merkel cell carcinoma: critical review with guidelines for multidisciplinary management
Christopher K Bichakjian, Lori Lowe, Christopher D Lao, et al.
Neuro-Oncology
|
January 16, 2016
Concurrent whole brain radiotherapy and RRx-001 for melanoma brain metastases
Michelle M Kim, Hemant Parmar, Yue Cao, et al.
American Journal of Clinical Pathology
|
October 23, 2012
Molecular diagnostics of melanoma fine-needle aspirates: a cytology-histology correlation study
Kurt D Bernacki, Bryan L Betz, Helmut C Weigelin, et al.
Advances in Radiation Oncology
|
December 22, 2021
Complete Response After Stereotactic Body Radiation Therapy With Concurrent Immunotherapy for Vaginal Melanoma
Caitlin A Schonewolf, Elizabeth M Jaworski, Steven G Allen, et al.
Cancer
|
April 10, 2004
Dysplasia in Barrett esophagus
Christopher D Lao, Melanie Simmons, Sapna Syngal, et al.
Journal of the American Academy of Dermatology
|
May 17, 2011
Feasibility of serial biopsies of large dysplastic nevi as a melanoma chemoprevention model
Christopher D Lao, Timothy Johnson, Vernon K Sondak, et al.
Plos One
|
December 11, 2012
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
Shailender Bhatia, James Moon, Kim A Margolin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2012
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438)
Kim A Margolin, James Moon, Lawrence E Flaherty, et al.
Page
of 9